More on the CMO Network
The Global CMO Network was established in 2014 to bring together the energy, experience and insight of Global Chief Medical Officers (CMOs) from some of the world’s biggest organisations to deliver meaningful improvements to people’s lives.
The Network is underpinned by the belief that the private sector has a responsibility to tackle some of the world’s biggest health challenges through workplaces to improve the wellbeing of employees, their families and the wider community.
Below is the Health: Our Business series, a collection of workplace health reports published by the Network, and further information about their stance on antibiotic resistance.
Poor mental health impacts everyone, either directly or indirectly, and depression is expected to be the leading disease burden by 2030 (Source: WHO, 2012) — hampering the success of the UN’s Sustainable Development Goals. The CMO Network is committed to tackling this challenge and continues to focus on making significant positive improvements by leveraging its collective impact.
One element of tackling this challenge is by launching the third volume in the series of Health: Our Business which includes case studies on existing mental health programmes from nine organisations: Emirates, GSK, International SOS, KPMG, MSD, Network Rail, Sibanye Stillwater, Unilever and Bupa. In addition to showcasing examples of positive mental health and wellbeing initiatives, this report contains recommendations to guide other organisations in implementing a mental wellbeing programme of their own.
The global Chief Medical Officers’ (CMO) Network is a group of world-leading clinicians, powered by Bupa, which is committed to bringing about a lasting improvement to the world’s health.
Together, they can leverage their combined insight, experience and global reach to solve some of the world’s biggest health problems - namely heart disease, cancer, diabetes and mental health - through workplace health initiatives. The network comprises of Chief Medical Officers from some of the world’s most innovative businesses, such as GSK, Unilever, Intel and Walmart, who have collective responsibility of a workforce of over eight million people.
To bring about significant, scalable and sustained improvements in workplace health, the network is focusing on behaviour change.
The network has compiled its second report, Health: Our Business II, which shares case studies from the corporate world, how businesses are putting health and wellbeing into action.
The first in a series of reports, this volume aims to identify what the greatest opportunities are in workplace health. We asked 32 of the world’s leading experts in workplace health and behaviour change from a variety of backgrounds to be involved. The report categorises insights into five key themes; workplaces of the future, improving employee engagement, a new role for CMOs, public and community health and digital opportunities.
This report is both a manifesto for future action and a catalyst for things to come. Our network is open, growing, collaborative and ambitious to act. It is also therefore an invitation to anyone out there who would like to join us on this journey.
Resistance to antibiotics is one of the biggest threats to global health. As bacteria develop resistance, antibiotics are starting to fail, meaning that without urgent action, we are heading for an era where common infections and minor injuries could once again kill.
View our infographic on the steps we can take to reduce antimicrobial resistance.
The CMO Network, powered by Bupa, has signed a pledge that urges companies to support the appropriate use of antibiotics, in order to help people live longer, healthier, happier lives.
Antibiotics are medicines that kill or interfere with the growth of bacteria. Antibiotic resistance is when bacteria are no longer killed by an antibiotic – instead they continue to grow and multiply in its presence. It threatens the prevention and treatment of a range of infections caused by bacteria, ranging from sinus infections and food poisoning to meningitis and pneumonia.
2. What are the effects of antimicrobial resistance? 2. What are the effects of antimicrobial resistance?
Antibiotic resistance makes it more difficult and expensive to treat infections. It can lead to longer hospital stays and higher medical costs, and even increased rates of mortality.
If resistance trends continue, common surgical operations such as hip and knee replacements will become far riskier. Life-saving treatments (e.g. chemotherapy for cancer; dialysis for kidney failure) themselves become life-threatening as they suppress the immune system and expose already vulnerable patients to the dangers of resistant infections. Without urgent action, globally we are heading for an era where common infections and minor injuries could once again kill.
There are several things which can lead to increasing resistance of antibiotics. This can include:
- Over-prescription of antibiotics – around half of all antibiotics are prescribed for the wrong reasons.1
- Not finishing a full course of antibiotics.
- Sharing or using leftover antibiotics.
- Poor hygiene and sanitation.
There are several actions that can be taken to better protect people against antimicrobial resistance.
- Only use antibiotics when prescribed by clinicians in line with current guidelines.
- Not requesting antibiotics when clinicians advise they are not needed.
- Prevent infection by washing hands, preparing food hygienically, avoiding close contact with sick people, keeping vaccinations up to date.
- Strengthen infection prevention and control measures.
- Improve reporting and surveillance of antibiotic-resistant infections.
- Making information available on the impact of antibiotic resistance.
5. What are Bupa and the Global CMO Network doing about this? 5. What are Bupa and the Global CMO Network doing about this?
Members of the Global Chief Medical Officer (CMO) Network have signed a pledge that urges companies to support the appropriate use of antibiotics, as resistance is on the rise.
The CMO Network is a group of some of the world’s leading employers, powered by Bupa. Companies in the CMO Network employ around eight million people combined. Each signatory has committed to playing their part to help dramatically reduce the volume of antibiotics which are misused and, in turn, slow resistance among their workforce.